Tofatas 5mg Tablets | 100-Count | TOFACITINIB

🇮🇳 India Warehouse
TOFACITINIB — 5mg per tablet, 100-count pack.
JAK inhibitor for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and polyarticular juvenile idiopathic arthritis. One of the first approved oral biologics for RA.

Key warning: Black box warnings: serious infections, malignancy, MACE, and thrombosis. TB screening mandatory. Do not combine with biologics. Live vaccines contraindicated. Age 50+ with CV risk factors: consider alternatives.

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is Tofatas 5mg used for?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”JAK inhibitor for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and polyarticular juvenile idiopathic arthritis. One of the first approved oral biologics for RA.”}},{“@type”:”Question”,”name”:”What are the side effects of TOFACITINIB?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Serious infections (bacterial, viral, fungal), lymphoma risk, MACE (major adverse cardiovascular events), venous thromboembolism, elevated lipids, anemia, neutropenia.”}},{“@type”:”Question”,”name”:”Where does this ship from?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Ships from India Warehouse — international delivery worldwide.”}}]}

What is Tofatas 5mg (TOFACITINIB)?

JAK inhibitor for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and polyarticular juvenile idiopathic arthritis. One of the first approved oral biologics for RA.

How it Works

Inhibits JAK1 and JAK3, blocking signaling of pro-inflammatory cytokines including IL-2, IL-4, IL-7, IL-15, and IL-21 — reduces joint inflammation at the molecular level.

Quick Specs

Form Oral tablets — pre-dosed
Active Ingredient TOFACITINIB
Dose per Tablet 5MG
Pack Size 10×10 (100 tablets)
Storage Room temperature (15–25°C), cool dry place
Shelf Life 2–3 years (properly stored)

Common Side Effects

Serious infections (bacterial, viral, fungal), lymphoma risk, MACE (major adverse cardiovascular events), venous thromboembolism, elevated lipids, anemia, neutropenia.

Safety Warnings

⚠️ Black box warnings: serious infections, malignancy, MACE, and thrombosis. TB screening mandatory. Do not combine with biologics. Live vaccines contraindicated. Age 50+ with CV risk factors: consider alternatives.

🌏 International shipping: 7–14 days

Frequently asked questions

How does my subscription work?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

How do I edit what's in my plan?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Can I change my next delivery date?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

It's been a while since I took the quiz. Can I get a new recommendation?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Tofatas 5mg Tablets | 100-Count | TOFACITINIB”

Your email address will not be published. Required fields are marked *